Entries by Steve

Chemocentryx (CCXI) Position Has Increased by Baker Bros Advisors Lp; Southwestern Energy Co Com (SWN) Position Raised by Disciplined Growth Investors Inc

August 2, 2018 – By Mary Kidd Baker Bros Advisors Lp increased its stake in Chemocentryx Inc. (CCXI) by 743.85% based on its latest 2018Q1 regulatory filing with the SEC. Baker Bros Advisors Lp bought 364,965 shares as the company’s stock rose 32.26% while stock markets declined. The hedge fund held 414,029 shares of the […]

Chemocentryx (CCXI) Market Valuation Rose While P-A-W Capital Cut Position by $1.11 Million; American Intl Group (AIG) Stock Declined While Archon Partners Has Cut Position by $1.84 Million

August 2, 2018 – By Joe Cepeda P-A-W Capital Corp decreased its stake in Chemocentryx Inc (CCXI) by 53.13% based on its latest 2018Q1 regulatory filing with the SEC. P-A-W Capital Corp sold 85,000 shares as the company’s stock rose 32.26% while stock markets declined. The hedge fund held 75,000 shares of the health care […]

$-0.40 EPS Expected for InflaRx N.V. (IFRX); Public Sector Pension Investment Board Increased By $36.00 Million Its Praxair (Put) (PX) Holding

August 2, 2018 – By Rhonda Roth Public Sector Pension Investment Board increased Praxair Inc (Put) (PX) stake by 250% reported in 2018Q1 SEC filing. Public Sector Pension Investment Board acquired 250,000 shares as Praxair Inc (Put) (PX)’s stock rose 0.80%. The Public Sector Pension Investment Board holds 350,000 shares with $50.51 million value, up […]

American Vanguard (AVD) Holder Jupiter Asset Management LTD Lowered Its Stake as Stock Price Rose; As Chemocentryx (CCXI) Share Price Rose, Strs Ohio Has Cut Its Stake by $396,500

August 1, 2018 – By Rhonda Roth Jupiter Asset Management Ltd decreased its stake in American Vanguard Corp (AVD) by 6.53% based on its latest 2018Q1 regulatory filing with the SEC. Jupiter Asset Management Ltd sold 26,522 shares as the company’s stock rose 4.90% while stock markets declined. The institutional investor held 379,851 shares of […]

Momenta Pharmaceuticals, Inc. (MNTA) EPS Estimated At $-0.46; Shorts at Chemocentryx (CCXI) Lowered By 2.85%

July 31, 2018 – By Ira Colvard Chemocentryx Inc (NASDAQ:CCXI) had a decrease of 2.85% in short interest. CCXI’s SI was 2.45 million shares in July as released by FINRA. Its down 2.85% from 2.52M shares previously. With 277,400 avg volume, 9 days are for Chemocentryx Inc (NASDAQ:CCXI)’s short sellers to cover CCXI’s short positions. […]

Apremilast Effective, Safe in Hidradenitis Suppurativa

July 31, 2018 Apremilast 30 mg given twice per day for 16 weeks resulted in clinically meaningful improvements in patients with moderate HS. Apremilast 30 mg twice daily is an effective anti-inflammatory treatment in patients with hidradenitis suppurativa (HS), according to study results published in […]

The Association Between Skin Diseases and Metabolic Syndrome

July 31, 2018 Investigators note that patients with hidradenitis suppurativa have one or more components of metabolic syndrome and advise targeted screening in young patients. A reciprocal relationship has been demonstrated between skin diseases and metabolic syndrome (MeTS), with therapeutic interventions in patients with MeTS […]